IDIOSYNCRATIC REACTIONS TO ANTIDEPRESSANTS - A REVIEW OF THE POSSIBLE MECHANISMS AND PREDISPOSING FACTORS

被引:15
作者
PIRMOHAMED, M [1 ]
KITTERINGHAM, NR [1 ]
PARK, BK [1 ]
机构
[1] UNIV LIVERPOOL,DEPT PHARMACOL & THERAPEUT,POB 147,LIVERPOOL L69 3BX,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1016/0163-7258(92)90046-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antidepressants, a widely used group of drugs, are associated with a range of idiosyncratic reactions affecting in particular the liver, skin and both the hematological and central nervous systems. These reactions seem to be mediated by chemically reactive metabolites formed by the cytochrome P450 enzyme system, the toxicity occurring either directly or indirectly via an immune mechanism. Individual susceptibility is determined by factors, both genetic and environmental, which result in inadequate detoxication of the chemically reactive metabolite. Prevention of such reactions will depend on either the development of new compounds which are not converted to toxic metabolites or by prediction of individual susceptibility prior to drug administration.
引用
收藏
页码:105 / 125
页数:21
相关论文
共 145 条
[1]   TOXICITY OF TRICYCLIC ANTIDEPRESSANTS TO ISOLATED RAT HEPATOCYTES [J].
ABERNATHY, CO ;
LUKACS, L ;
ZIMMERMANN, HJ .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (03) :347-350
[2]  
ADKINSON NF, 1983, 11 P INT C ALL CLIN, P55
[3]  
ALBERTINI RS, 1978, J CLIN PSYCHIAT, V39, P483
[4]   DRUG-INDUCED RED-CELL DYSCRASIAS [J].
AMMUS, S ;
YUNIS, AA .
BLOOD REVIEWS, 1989, 3 (02) :71-82
[5]  
AYESH R, 1989, RECENT ADV CLIN PHAR, P137
[6]  
Baldessarini RJ, 1985, PHARMACOL BASIS THER, P387
[7]   HEMATOLOGIC SIDE-EFFECTS OF PSYCHOTROPIC-DRUGS [J].
BALON, R ;
BERCHOU, R .
PSYCHOSOMATICS, 1986, 27 (02) :119-&
[8]   FLUVOXAMINE AND LIVER-ENZYMES [J].
BAMRAH, JS ;
BENBOW, SM ;
MCKENNA, J .
BRITISH JOURNAL OF PSYCHIATRY, 1990, 156 :286-287
[9]  
BANDT C, 1964, JAMA-J AM MED ASSOC, V188, P752
[10]   METABOLISM OF AMITRIPTYLINE, NORTRIPTYLINE, IMIPRAMINE AND ESIPRAMINE TO YIELD HYDROXYLAMINES [J].
BECKETT, AH ;
ALSARRAJ, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) :335-336